Dr. Christoph Riplinger is a trained biochemist. During his academic career with the German Max Planck Society and Princeton University he developed quantum chemical methods that allow for an accurate prediction of molecular properties, which can be used in combination with, or replace, experimental data. After growing interest in his work from the Pharmaceutical and Chemical industry he co-founded FACCTs GmbH as Managing Director. With FACCTs he now leads the further development of new and ground-breaking predictive methods for Life Science applications, Spectroscopy and Catalysis, with successful collaborations across Pharma partners.